glp-1 chart Receptor Agonist Market Size GLP-1 Trends

According to research, those taking semaglutide, marketed under brand names like Ozempic and Wegovy, may report an increase in gastrointestinal symptoms, including burping

(1994) Structure-activity relationships of glucagon-like peptide-1(7-36)amide: insulinotropic activities in perfused rat pancreases, and receptor binding and cyclic AMP production in RINm5F cells

The results showed that intra-articular injection of liraglutide alleviated pain-related behavior in in vivo sodium monoiodoacetate OA mouse model, which was probably driven by the GLP-1R-mediated anti-inflammatory activity of liraglutide

FDA.gov Sanyal AJ, Cusi K, Hartman ML, et al

GLP-1 is short for glucagon-like peptide-1

Reports of emotional blunting and loss of pleasure come largely from individual patient experiences, post-marketing observations and emerging research into how GLP-1 signalling interacts with the brain